Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Blood Culture Testing: Send Samples Selectively to Lower Costs, Medico-Legal Risk

By Jeremiah D. Schuur, MD, MHS and Michelle Lin, MD, MPH | on September 12, 2014 | 2 Comments
Cost-Effective Care
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
"Arm Yourself For the ""Cultural"" Debate "
Table 1. How to Reduce False-Positive Blood Cultures

You Might Also Like
  • Blood Culture of Limited Value in Most Kids Hospitalized with Community-Acquired Pneumonia
  • Praise for Evidence-Based Advice on Prescribing Antibiotics, Testing Blood Cultures
  • Should Emergency Department Patients with Pending Blood Cultures be Admitted?
Explore This Issue
ACEP Now: Vol 33 – No 09 – September 2014

Table 1. How to Reduce False-Positive Blood Cultures

Patients with cellulitis. These patients have a pretest probability for bacteremia of 2 percent, so blood cultures in this population are very low yield.9 Numerous studies have documented the predominance of strep and staph species in skin and soft tissues infections; thus when antibiotics are indicated, they may be initiated empirically

Patients with uncomplicated pyelonephritis. Urine cultures are higher yield than blood cultures. In the rare cases where blood cultures identify organisms, they rarely differ from those identified in urine and very rarely alter clinical management.10

Patients being discharged from the ED. Blood cultures are a test for bacteremia, and bacteremia is a serious condition requiring close monitoring—ergo, you should not send blood cultures on patients being discharged from the ED. Outpatient blood cultures expose you to significant medical legal risk as positive results require contacting the patient and determining if further ED or inpatient care is needed. Like any general rule, there are exceptions: nonacute diseases for which blood cultures are the diagnostic test of choice, such as subacute bacterial endocarditis. If you will be sending blood cultures on an outpatient, be clear who will follow up on the results and make sure you have correct contact information.

Patients with normal vital signs or those with isolated fever and otherwise normal vital signs. The presence of systemic inflammatory response syndrome (SIRS) was found to be 96 percent sensitive for bacteremia among patients who had blood cultures drawn on a general medical service, meaning that the absence of SIRS greatly reduces the likelihood of bacteremia.11

What about patients with sepsis? The Surviving Sepsis Campaign recommends blood cultures as part of the three-hour bundle for patients with severe sepsis or septic shock (based on low-strength evidence).12 This accounts for a small proportion of the patients with the above-mentioned infections.

What Can You Do to Improve the Cost-Effectiveness of Blood Culture Testing?

Do not send blood cultures on patients for whom you have a low clinical suspicion of bacteremia. Talk to your clinical director about removing blood cultures from routine order sets for patients with community-acquired pneumonia, cellulitis, and urine infections including pyelonephritis. Have an educated discussion with the next admitting physician who asks if you sent cultures on the pneumonia patient you are admitting to the floor; the references for this article should be the evidence they need!

When cultures are sent, be sure they are collected appropriately to minimize contamination (see Table 1). Consider a protocol to have cultures drawn by staff trained in blood culture collection technique, and reinforce best practices with your staff.

Pages: 1 2 3 4 | Single Page

Topics: Cost of Health CareEmergency MedicineLab TestLegalPractice ManagementQuality

Related

  • Florida Emergency Department Adds Medication-Dispensing Kiosk

    November 7, 2025 - 1 Comment
  • Q&A with ACEP President L. Anthony Cirillo

    November 5, 2025 - 0 Comment
  • How Does Emergency Medicine Navigate Consolidation Trends in Health Care?

    October 29, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

About the Authors

Jeremiah D. Schuur, MD, MHS

Jeremiah D. Schuur, MD, MHS, is vice chair of quality and safety and chief of the Division of Health Policy Research and Translation in the Department of Emergency Medicine, Brigham & Women’s Hospital in Boston. He also serves as assistant professor at Harvard Medical School.

View this author's posts »

Michelle Lin, MD, MPH

Michelle Lin, MD, MPH, is an attending emergency physician and a fellow in the Division of Health Policy Research and Translation in the Department of Emergency Medicine, Brigham and Women’s Hospital in Boston. She also serves as an instructor at Harvard Medical School.

View this author's posts »

2 Responses to “Blood Culture Testing: Send Samples Selectively to Lower Costs, Medico-Legal Risk”

  1. October 4, 2014

    Culooch Reply

    Great article!

    In future versions would be useful to discuss the cost of false positive cultures (usually $4000-7000 per false positive in a hospitalized patient)

    Also it is not so important whether or not a culture is positive but rather how often does it change management. While 4% of ED drawn blood cultures may be positive (and half of those being false positives) a positive culture almost never prompts a change in abx. When it does, it is almost always in a immunosuppressed patient orthose with severe sepsis/septic shock

  2. June 10, 2015

    Delores Lyon Reply

    Wow, I had no idea that blood cultures could be so inaccurate. With a false positive testing rate of 40%, that is a lot of unnecessary follow up. In my opinion, if I was sick for some reason, I would probably want my doctor to forego something like this. The last thing I want is unnecessary medical bills.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603